(-0.88%) 4 967.23 points
(0.56%) 37 986 points
(-2.05%) 15 282 points
(0.62%) $83.24
(0.17%) $1.760
(0.36%) $2 406.70
(1.29%) $28.75
(-1.17%) $943.30
(-0.14%) $0.938
(-0.21%) $11.02
(0.56%) $0.808
(-0.95%) $93.01
@ $22.40
Issued: 13 Feb 2024 @ 09:30
Return: -11.29%
Previous signal: Feb 12 - 09:36
Previous signal:
Return: -3.80 %
Live Chart Being Loaded With Signals
AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications...
Stats | |
---|---|
Today's Volume | 281 568 |
Average Volume | 325 117 |
Market Cap | 531.78M |
EPS | $0 ( 2024-03-13 ) |
Next earnings date | ( $-1.540 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.27 |
ATR14 | $0.0340 (0.17%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-22 | Faga Daniel | Sell | 145 940 | Common Stock |
2024-03-25 | Faga Daniel | Sell | 3 000 | Common Stock |
2024-03-26 | Faga Daniel | Sell | 347 441 | Common Stock |
2024-02-16 | Loumeau Eric J | Sell | 5 000 | Employee Stock Option (right to buy) |
2024-02-16 | Loumeau Eric J | Buy | 5 000 | Common Stock |
INSIDER POWER |
---|
37.57 |
Last 98 transactions |
Buy: 3 215 504 | Sell: 1 263 529 |
Volume Correlation
AnaptysBio Inc Correlation
10 Most Positive Correlations | |
---|---|
CDXS | 0.959 |
TRIP | 0.957 |
ZD | 0.956 |
SRTS | 0.954 |
CSGS | 0.953 |
ETSY | 0.95 |
LGHL | 0.944 |
HNNA | 0.941 |
NMTR | 0.94 |
VERI | 0.94 |
10 Most Negative Correlations | |
---|---|
MSDA | -0.938 |
DHAC | -0.929 |
MCAA | -0.928 |
MYRG | -0.92 |
BRIV | -0.918 |
RELY | -0.917 |
SKYA | -0.917 |
BRIVU | -0.916 |
FICV | -0.914 |
ADAL | -0.914 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
AnaptysBio Inc Correlation - Currency/Commodity
AnaptysBio Inc Financials
Annual | 2023 |
Revenue: | $17.16M |
Gross Profit: | $14.78M (86.15 %) |
EPS: | $-6.08 |
Q4 | 2023 |
Revenue: | $9.01M |
Gross Profit: | $8.40M (93.29 %) |
EPS: | $-1.590 |
Q3 | 2023 |
Revenue: | $3.32M |
Gross Profit: | $2.73M (82.16 %) |
EPS: | $-1.410 |
Q2 | 2023 |
Revenue: | $3.46M |
Gross Profit: | $2.87M (83.03 %) |
EPS: | $-1.500 |
Financial Reports:
No articles found.
AnaptysBio Inc
AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor (IL-36R) for the treatment of various dermatological inflammatory diseases; Rosnilimab, an anti-PD-1 agonist antibody program designed to augment PD-1 signaling through rosnilimab treatment to suppress T-cell driven human inflammatory diseases; and ANB032, an anti-BTLA modulator antibody applicable to human inflammatory diseases associated with lymphoid and myeloid immune cell dysregulation. The company also focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has a collaboration and license agreement with GlaxoSmithKline, Inc. and Bristol-Myers Squibb; and license agreements with United Kingdom Research and Innovation, as well as Millipore Corporation. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators